BLTE

BELITE BIO INC

BLTE·07782B104·US·ADR·Healthcare - Biotechnology-13D/G

BLTE institutional ownership changes in Q2 2026: 24 institutions opened or added positions, 22 trimmed or exited. BLTE (BELITE BIO INC) is held by 41 institutional investors as of Q2 2026. Top institutional shareholders: RTW INVESTMENTS, LP ($110.2M), MILLENNIUM MANAGEMENT LLC ($76.2M), MAVERICK CAPITAL LTD ($61M). Net institutional sentiment: Mixed.

41
Holders
(3 Elite)
$542.1M
Total Value
52% (46)
Consensus
24 buying - 22 selling
13F: Insider & Congress: Updated regularly
BLTE

Smart Money Verdict

View all
Loading verdict
Held by 41 funds
3 elite

Who's Trading

Source dates: Price Oct 23, 2026 · Insiders Oct 5, 2026 · Activists May 14, 2026 · Congress none

InsiderSPScholl Hendrik PeterSell $340.04Oct 1, 2026
InsiderSPScholl Hendrik PeterSell $13KOct 1, 2026
InsiderSPScholl Hendrik PeterSell $20KOct 1, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
715,332$110.2M0.9%+20.36%
0
Decreased
494,564(-13.3%)$76.2M0.0%-6.05%
0
New
396,311$61M0.5%-4.32%
58
Decreased
251,035(-49.2%)$38.7M0.1%-7.65%
0
Increased
235,071(+16.7%)$36.2M0.0%-6.03%
34
Decreased
224,989(-70.7%)$34.6M0.0%-6.88%
0
Increased
186,168(+9171.3%)$28.7M0.0%-3.67%
46
Increased
166,188(+57.5%)$25.6M0.0%-5.36%
41
Increased
124,783(+3202.9%)$19.2M0.0%-3.82%
46
Unchanged
106,100$16.3M0.3%-7.60%
0
Decreased
105,859(-62.4%)$16.3M0.0%-7.60%
0
Increased
65,801(+438.4%)$10.1M0.0%-5.01%
45
Increased
57,125(+75.6%)$8.8M0.0%-3.85%
42
Increased
55,763(+7.2%)$8.6M0.0%-7.38%
30
New
51,186$7.9M0.0%-4.32%
38
Increased
49,516(+228.5%)$7.6M0.0%-5.34%
44
New
38,100$5.9M0.0%-4.32%
38
Increased
33,181(+11.1Kx)$5.1M0.0%-4.32%
44
New
31,721$4.9M0.0%-4.32%
37
Increased
22,640(+117.1%)$3.5M0.0%+37.20%
43

Showing 1-20 of 50

1 / 3
BLTEBLTEBELITE BIO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used